1. Home
  2. TMDX vs CNS Comparison

TMDX vs CNS Comparison

Compare TMDX & CNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

N/A

Current Price

$78.39

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Logo Cohen & Steers Inc

CNS

Cohen & Steers Inc

N/A

Current Price

$69.23

Market Cap

4.4B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TMDX
CNS
Founded
1998
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
4.4B
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
TMDX
CNS
Price
$78.39
$69.23
Analyst Decision
Buy
Hold
Analyst Count
13
3
Target Price
★ $99.82
$72.00
AVG Volume (30 Days)
★ 681.0K
238.1K
Earning Date
10-28-2026
10-15-2026
Dividend Yield
N/A
★ 3.79%
EPS Growth
★ 382.18
N/A
EPS
0.61
★ 1.77
Revenue
★ $605,494,000.00
$427,536,000.00
Revenue This Year
$22.50
$10.54
Revenue Next Year
$17.93
$10.14
P/E Ratio
$129.51
★ $39.95
Revenue Growth
★ 37.13
4.07
52 Week Low
$60.11
$58.39
52 Week High
$156.00
$86.56

Technical Indicators

Market Signals
Indicator
TMDX
CNS
Relative Strength Index (RSI) 39.81 25.23
Support Level $66.64 $68.02
Resistance Level $79.60 $69.40
Average True Range (ATR) 3.82 2.05
MACD -0.63 -0.17
Stochastic Oscillator 11.98 2.35

Price Performance

Historical Comparison
TMDX
CNS

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About CNS Cohen & Steers Inc

Cohen & Steers is a niche asset manager concentrating on real estate securities. The firm invests primarily in the equity shares of real estate investment trusts, with holdings in domestic and international real estate securities accounting for nearly two-thirds of its $102.5 billion in managed assets at the end of July 2026. Cohen & Steers also manages portfolios dedicated to preferred securities, utilities stocks, and other high-yield offerings. The firm's distribution is balanced among its closed-end funds, open-end funds, and institutional accounts. During the past four calendar quarters, the company garnered 39% (25%) of its managed assets (base management fees) from institutional clients, 48% (55%) from open-end funds, and 13% (20%) from closed-end funds.

Share on Social Networks: